Different Response of Ptch Mutant and Ptch Wildtype Rhabdomyosarcoma Toward SMO and PI3K Inhibitors
Rhabdomyosarcoma (RMS) is the most common pediatric soft tissue sarcoma with poor prognosis. RMS frequently show Hedgehog (HH) pathway activity, which is predominantly seen in the embryonal subtype (ERMS). They also show activation of Phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) signaling....
Main Authors: | Natalie Geyer, Rosalie Ridzewski, Julia Bauer, Maria Kuzyakova, Kai Dittmann, Christian Dullin, Albert Rosenberger, Hans-Ulrich Schildhaus, Anja Uhmann, Simone Fulda, Heidi Hahn |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2018.00396/full |
Similar Items
-
Ptch2 is a Potential Regulator of Mesenchymal Stem Cells
by: Emma Juuri, et al.
Published: (2022-04-01) -
Sustained Suppression of Gorlin Syndrome-Associated Basal Cell Carcinomas with Vismodegib or Sonidegib: A Case Series
by: Raquel Wescott, et al.
Published: (2023-10-01) -
Basal cell cancer treatment. Therapeutic experience with vismodegib therapy
by: N. N. Petenko, et al.
Published: (2018-07-01) -
Treatment of Advanced Basal Cell Carcinoma with Hedgehog Pathway Inhibitors: A Multidisciplinary Expert Meeting
by: Vincenzo De Giorgi, et al.
Published: (2021-11-01) -
Unexpected phenotype in a frameshift mutation of PTCH1
by: Benedetta Beltrami, et al.
Published: (2020-01-01)